Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature

IntroductionAs the global pandemic continues, new complications of COVID-19 in pediatric population have turned up, one of them being hemolytic uremic syndrome (HUS), a complement-mediated thrombotic microangiopathy (CM-TMA) characterized by triad of thrombocytopenia, microangiopathic hemolytic anem...

Descripció completa

Dades bibliogràfiques

Autors principals:	Matija Matošević, Ivanka Kos, Maša Davidović, Maja Ban, Hana Matković, Ivan Jakopčić, Ivana Vuković Brinar, Ágnes Szilágyi, Dorottya Csuka, György Sinkovits, Zoltán Prohászka, Kristina Vrljičak, Lovro Lamot
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-02-01
Col·lecció:	Frontiers in Pediatrics
Matèries:	hemolytic uremic syndrome HUS thrombotic microangiopathy TMA COVID-19 complement blockade
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fped.2023.1092860/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!